Introduction
Feline immunodeficiency virus (FIV) was isolated in 1986 from immunodeficient domestic cats in California (Pedersen et al., 1987) and has since been isolated in a number of different countries (Harbour et al., 1988; Ishida et al., 1988) . There is no statistical linkage between FIV and feline leukaemia virus (FeLV) , a retrovirus that also causes signs of immunosuppression in cats. FIV has a tropism for T lymphocytes (Pedersen et al., 1987) and has been propagated in Crandell feline kidney (CrFK) cells ) and the permanent feline T cell lines LSA-1 (Yamamoto et al., 1986) and MVA-1 (Miyazawa et al., 1989) . In vivo and in vitro infection of peritoneal macrophages of cats was reported by Brunner & Pedersen (1989) . Several proteins encoded by FIV gag, pol and env genes have been identified; the gag gene encodes a polypeptide precursor with an apparent Mr of 50K (Talbott et al., 1989; Egberink et al., 1990; Steinman et al., 1990) . When this protein is cleaved by the protease encoded by the pol gene, the major core protein p24 and at least two more proteins, p15 and pl0, are produced (Egberink et al., 1990; Steinman et al., 1990) . Quantitative measurement of FIV has been conducted by immunofluorescence or by detection of reverse transcrip-0000-9853 © 1991 SGM tase activity in tissue culture supernatants. However, for many studies a plaque assay using susceptible cells adherent to plastic would be more convenient. In this report we describe the production and characterization of two monoclonal antibodies (MAbs) specific for FIV gag gene products and their use in a simple assay to titrate infectious virus doses and neutralizing antibody activity.
Methods
Virus and cell lines. The FIV Petaluma strain was propagated in persistently infected CrFK cells as previously described (Pedersen et al., 1987; Yamamoto et al., 1988) . This cell line is free of feline syncytium-forming virus (FeSFV) and feline infectious peritonitis virus (FIPV) as determined by an indirect immunofluorescence assay (IFA) and by immunoblot analysis using cat sera for FeSFV (Merieux) and FIPV-I and -II (American Bioresearch), respectively. A microcarrier technique was employed to increase virus production by FIV-infected CrFK cells (FIV/CrFK). Briefly, 1-5 g of preswollen Cytodex 1 microcarrier beads (Pharmacia) were seeded with 6x 107 FIV/CrFK cells in 100 ml of Dulbecco's modified Eagle's medium (DMEM), 10% heat-inactivated foetal bovine serum (FBS) and 1% antibioticantimycotic (Gibco), and incubated at 37 °C with stirring (20 r.p.m.) for 2 min every 30 rain for 4 to 5 h in a spinner vessel (Techne MCS-104 S). The culture volume was later increased to 500 ml. Virus was concentrated from tissue culture supernatants by precipitation with polyethylene glycol as described (Bishop et al., 1971) . The precipitated proteins and virus were layered over a double cushion of 20 and 80~ (w/v) sucrose and centrifuged for 120 min at 25000 r.p.m, in a Beckman SW27 rotor. The band of material between the sucrose layers was collected and diluted in 0.15 M-NaC1, 0"01 M-Tris-HC1 buffer pH 7.5. After a two-step differential centrifugation at 6000 r.p.m, for 20 min and 11000 r.p.m, for 10 min in a Beckman 30 rotor, the supernatant was filtered through a 0-45 ~tm Millipore filter and the virus pelleted by a final centrifugation at 30000 r.p.m, for 30 min. All procedures were carried out at 4 °C. The other viruses used as antigens were human immunodeficiency virus type 1 (HIV-1), human T cell leukaemia virus type 1 (HTLV-1), the Rickard strain of FeLV, FeSFV, endogenous cat virus RD114, equine infectious anaemia virus (EIAV) and visna virus (VV). FeLV was produced in the FL-74 feline T lymphoblastoid cell line and purified as previously described (Noronha et al., 1977) ; RD114 virus was prepared from RD114B cell extracts and FeSFV (Cornell and ATCC isolates) was cultivated in CrFK ceils. VV was grown in lamb testicle primary cultures. EIAV was propagated in the equine dermal cell line CCL57.
Virus isolation. FIV was isolated from peripheral blood mononuclear cell (PBMC) cultures of experimentally FIV-infected cats as previously described (Pedersen et al., 1987) . Virus replication was monitored by a standard reverse transcriptase assay, IFA and immunocytochemistry.
MAb production. BALB/c mice (2 months old) were immunized intraperitoneally with a 0.2 ml emulsion of 50 txg of purified FIV in phosphate-buffered saline (PBS) and Freund's complete adjuvant (1 : 1). Inoculations were repeated with the same amount of virus in Freund's incomplete adjuvant after 2 weeks, and in PBS after 4 weeks. The mice were given intraperitoneal and intravenous inoculations with disrupted virus in PBS 30 days later. Four days following the final booster, the spleens were removed and desegregated and red blood cells were lysed in 0.16 M-NH4C1, 0-017 M-Tris buffer pH 7.65. Fusion and cloning were done as described previously (Youngren et at., 1984) . Viable hybridoma clones were tested for virus-specific antibody by ELISA, with purified FIV and normal CrFK cell lysates as coating antigens. Cell lines producing antibodies were cloned three times by limiting dilution and expanded in spinner vessels (20 r.p.m.) in a reduced serum medium, Opti-MEM I (Gibco), containing 2-5~ heatinactivated FBS and 1 ~ antibiotic-antimycotic (Gibco), at 37 °C in an 8~ COz humidified atmosphere. Antibodies were purified from cellfree culture media by Protein A-Sepharose CL-4B (Phannacia) affinity chromatography. Protein concentrations were estimated by the method of Lowry et al. (1951) .
ELISA. Purified viral pellets and CrFK cells were disrupted in 0.05 M-Tris-HCI pH 7.8, 0.1 M-KC1, 0.5~ Triton X-100 and 0.001 M-DTT for 2 h at 4 °C with gentle stirring. Undisrupted virions were removed by centrifugation at 105000 g for 30 min at 4 °C (Beckman type 30 rotor). CrFK cell lysates were clarified at 5000 g for 20 min at 4 °C. ELISA plates (Immulon; Dynatec Laboratories) were coated overnight at 4 °C with approximately 1 Ixg/100 ktl/well virus or cell lysates in carbonate buffer (pH 9-6). The plates were subsequently coated with 2~ FBS to block available sites for non-specific binding and stored at 4 °C. Bound antibodies were revealed by a peroxidaseconjugated rabbit anti-mouse IgG (Sigma) diluted at 1:1000 in PBS/0.02% Tween 20 containing 2~ FBS. The enzyme reaction was carried out with 0-1~ tetramethylbenzidine and 0.04~ hydrogen peroxide in 0.025 M-citric acid, 0-05 M-sodium acetate buffer. The reaction was stopped with 0-2 M-H2S04 and the absorbance was measured at 450 nm. Antigenic cross-reactivity with MAbs against HIV-1 and HTLV-1 was assessed by using precoated ELISA plates containing disrupted HIV-1 and HTLV-1 virus, respectively, kindly provided by Dr R. Gallo (Bethesda, Md., U.S.A.).
IFA. Cat PBMC and CrFK cells were used for immunofluorescent staining. Live infected PBMC (2.5 x l0 s cells) were washed twice with PBS and pelleted at 300 g for 5 min. Undiluted cell-free supernatant from hybridoma cell line 3B7 (or 1Cll) was then added. Following incubation for 30 min at room temperature (RT), the cells were washed and incubated with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG (Sigma) for an additional 30 min at RT. The cells were then washed, resuspended in PBS, mounted on slides and examined with a fluorescence microscope.
FIV/CrFK cells were trypsinized, resuspended in culture medium (4 × l0 s cells/ml) and spotted into six wells of a 12-well Teflon-coated slide; adjacent wells were seeded with an equal number of uninfected negative control cells. After an adsorption period of 1 to 2 h at 37 °C, the cells were fixed with cold acetone forl0 min, air-dried and stored at -20 °C. The incubation steps with the MAbs and FITC-conjugated goat anti-mouse IgG were done at 37 °C for 30 min.
Virus titration using MAbs 3B7 and 1Cll. CrFK cells (2.5 x 10s/5 ml) were seeded into 2 mm gridded, 60 mm diameter Petri dishes in DMEM supplemented with 10~ heat-inactivated FBS, 2 ~tg/ml polybrene (Aldrich) and antibiotics. The plates were incubated at 37 °C in a 5 ~ CO2 humidified atmosphere overnight. Medium was removed and serial dilutions of the virus in DMEM were added to the plates (three per dilution; 0.2 ml/plate). After a 1 h adsorption period at 37 °C, the monolayers were washed and fresh medium was added. The plates were incubated for 4 days at 37 °C and then washed and fixed with 10~ buffered formalin. Undiluted cell-free supernatant (2 ml) from hybridoma cell line 3B7 (or 1Cll) was added for a period of 30 to 45 rain at 37 °C. The plates were washed with PBS and a biotinylated rabbit anti-mouse antibody was added for 10 rain at 37 °C. They were then rinsed and incubated for an additional 10 min with streptavidin peroxidase (Zymed Laboratories) diluted 1:20 in PBS. The substrate solution (H202 and aminoethyl carbazole) was added and the reaction was stopped after 5 to 15 min with distilled water. After staining with haematoxylin the foci were counted using a microscope at 35 x magnification. A viral stock obtained from cell-free supernatants of a 5 day culture of FIV-infected CrFK cells was titrated, and kept in aliquots in liquid nitrogen for use in neutralization assays.
Neutralization assay. Filter-sterilized MAbs (0.1 mg/ml) were preincubated with an equal volume of virus (100 f.f.u.) for 1 h at RT, then virus-MAb mixtures were added (0.2 ml/plate) and incubated for 1 h at 37 °C. The plates were further incubated for 4 days at 37 °C and the number of foci was scored as described above. Three plates were used for each MAb tested and three other plates with a MAb of irrelevant specificity served as virus controls. The neutralization titres were determined by using the 50~ (VJV o = 0.5) neutralizing point, where V n is the number of f.f.u, and V 0 is the total number of f.f.u in the control to which the MAb of irrelevant specificity was added. MAbs causing a 50~ or greater reduction of the average focus number compared to control plates were considered to be positive.
For seroconversion studies, eight specific pathogen-free (SPF) kittens of both sexes at 6 to 10 weeks of age were infected by a subcutaneous (s.c.) inoculation of 3 x 103 f.f.u, of FIV in 2 ml DMEM. In addition, cat 642 was inoculated twice and cat 671 once with their own virus isolates at 47 and 49 weeks, and at 50 weeks after the first inoculation, respectively. Inoculations were performed s.c. with 10 x 106 infected PBMCs in 2 ml RPMI 1640. The cats were bled regularly for virus isolation and to determine antibody specificity. Sera from 13 cats with non-specific illness were also tested. All samples were heat-inactivated for 30 rain at 56 °C before testing. Twofold serial dilutions of the samples in DMEM were incubated in duplicate with 100 f.f.u, of FIV for 60 min at RT prior to inoculation onto CrFK cells; pooled normal SPF cat sera (diluted 1:10) were included as virus controls.
Kinetics of serum neutralization. Dilutions of an immune serum (cat 633 at 1:5000, l:10000 and 1:20000) were incubated with FIV (100 f.f.u.). The number of infectious virus particles remaining was measured at increasing times of incubation of the mixture on CrFK cells (Fig. 4) . The dishes were scored 4 days later as described above.
SDS-PAGE and Western blot procedure.
For Western blot (immunoblot) analysis, purified viral pellets and lysates of normal cells were separated by SDS-PAGE through a 12% gel with the buffer system described by Laemmli (1970) . After electrophoresis the proteins were transferred to nitrocellulose sheets (Towbin et al., 1979) and the sheets were placed in protein blocking solution [20 mM-Tris base, 500 mMNaC1 pH 7.4 (TBS), containing 2% bovine serum albumin and 0-02% Tween 20]. The blots were then incubated with undiluted hybridoma supernatants at 4 °C overnight and, after extensive washing in TBS-0.02% Tween 20, the bound antibodies were visualized by enzyme immunoassay using a biotinylated sheep anti-mouse and a streptavidin-biotinylated horseradish peroxidase complex (Amersham) diluted at 1:1000 in TBS-0.02% Tween 20 containing 2% FBS. The reaction was developed with a 4-chloro-1..naphthol/TBS, hydrogen peroxide substrate system until dark blue bands of the desired intensity appeared. Blots were also probed with a 1:100 dilution of polyspecific cat sera for FIV as a positive control.
To confirm that the proteins recognized by MAbs 3B7 and 1C11 were the same as those recognized by antibodies from FIV-infected cats, an affinity column was made. Protein A-purified MAb 3B7 was coupled to CNBr-activated Sepharose 4B (Pharmacia). Heat-inactivated, Triton X-100-disrupted virus was incubated at 4 °C overnight with 3B7-Sepharose. The column was extensively washed with PBS and bound protein(s) eluted with 1 mM-glycine buffer pH 2.5. Collected fractions were lyophilized and subjected to 13% SDS-PAGE, transferred to nitrocellulose paper and tested with a cat serum for FIV.
Biotinylation of MAbs and competition studies. Protein A-purified
MAbs were dialysed overnight against 0.1 M-NaHCO3 pH 8-4 at 4 °C and labelled with biotin-N-hydroxysuccinimide ester (BRL), according to the manufacturer's protocol. Estimates of antibody avidity and competition binding studies were performed (Shaw et al., 1986) . Competition was defined as significant if the concentration of an unlabelled heterologous MAb required to achieve 70% binding inhibition was less than 2.5-fold that of the concentration of the unlabelled homologous biotinylated MAb necessary to produce an equivalent degree of binding inhibition. lsotype determination. The Ig class of antibodies secreted by the established hybridoma cell lines was determined by ELISA as described above, using goat antisera to mouse IgG1, IgG2a, IgG2b, IgA and IgM, followed by horseradish peroxidase-labelled swine antiserum to goat Igs (Boehringer Mannhein). These MAbs were isotype IgG1 and both have x light chains.
Results

IFA and immunocytochemistry
The fluorescent labelling of virus-positive cells appeared to be within the cytoplasm as only fixed cells could be labelled (Fig. I a) . The same location of FIV antigens was shown by immunocytochemistry. None of the MAbs reacted with normal cat PBMC or CrFK cells by these methods. FIV foci on CrFK cells consist of both syncytia and single cells (Fig. 1 b) .
Western blot analysis
The specificities of the MAbs for viral proteins were characterized using a standard Western blot technique. MAbs 3B7 and 1Cll bound strongly to a protein band with an Mr of 24K and, with a lower intensity, to a band of 50K (Fig. 2) . Occasionally, the MAbs also reacted with two other bands at 15K and 10K (data not shown); the antibodies did not react with uninfected cells. None Serum from a FIV-seropositive cat reacted with a single band of 24K on the Western blots of the eluted product(s) of the affinity column, whereas the same serum reacted with several additional viral proteins on the FIV blot (Fig. 3) . These results confirm that the protein recognized by MAbs 3B7 and 1C11 is FIV p24.
In vitro neutralization
A MAb that produced a 50% or greater reduction in the number of FIV foci scored at day 4 post-inoculation (p.i.) was considered to have neutralizing activity. At the concentration used (100 ~tg/ml) neither of the MAbs neutralized FIV.
Relative avidities of MAbs for FIV and competition binding studies
The relative avidities of MAbs 3B7 and 1C11 for FIV were determined by titration in ELISA. Both MAbs produced similar ELISA titres and achieved antigen saturation at 15 txg/well, suggesting similar avidities. The two MAbs significantly inhibited the binding of their biotinylated homologous and heterologous counterparts to viral antigens (data not shown).
Serology on FIV-infected cats
All experimentally FIV-infected cats developed neutralizing antibodies which were first detected at 3 to 4 weeks. These antibody titres progressively increased during the first year of infection, reaching titres of 1:5120 to 1:81960 which were maintained at 2.5 years ( Table 1) . The virus was reisolated several times in PBMC cultures from all cats and was detected after 2 to 4 weeks of cultivation as measured by reverse transcriptase activity and by IFA. During this study period all but two of the eight experimentally infected cats remained asymptomatic. Cats 642 and 671 showed persistent loose stools for more than 6 months and cat 642 lost weight. As shown in Table 2 , nine of the 13 clinical samples reacted with FIV proteins in Western blots. These sera showed neutralizing titres ranging from 1:1000 to greater than 1:2000. The other four non-reactive samples (6, 9, 10 and 13) did not have neutralizing activity at a 1:10 dilution.
As shown in Fig. 4 , neutralization of FIV was a linear function of the incubation time of virus with immune serum and the rate of neutralization changed with serum dilution.
Discussion
MAbs 3B7 and 1Cll have been described which react specifically with FIV p24 in ELISA, IFA, immunocytochemistry and Western blotting. MAbs 3B7 and 1Cll reacted strongly with a 24K protein and faintly labelled other bands at 50K, 15K and 10K. The relative size of these proteins is consistent with previously published data for FIV gag products (O'Connor et al., 1989; Olmsted et al., 1989; Egberink et al., 1990; Steinman et al., 1990) . This pattern could be attributed to recognition of both precursor and mature forms of the same gag proteins. These two MAbs showed identical avidities and, since they mutually inhibited each other's binding to the virus, they were considered to be directed against the same or closely related epitopes.
Immunofluorescent labelling of virus-infected cells using MAbs 3B7 and 1Cll was restricted to the cytoplasm. Only fixed cells were labelled, supporting the idea that p24 is an internal FIV protein. Identical results were obtained by immunocytochemistry. The latter test enabled the development of a simple and rapid in vitro neutralization assay, in which FIV infection foci can easily be scored using the MAbs. This assay could also be applied to evaluate the efficacy of anti-retroviral compounds in vitro.
The lack of neutralizing activity of the MAbs was expected. As with other lentiviruses, neutralizing antibodies are most likely to be directed against the envelope glycoprotein. 0  2  3  4  5  7  9  12  17  20 21  22  40  63  73  78  79  80  90  122  126  129 Serological studies in cats after experimental inoculation with FIV showed that they rapidly develop neutralizing antibodies. The maintenance of high levels of neutralizing antibodies for a long time period (2.5 years) and the concurrent isolation of the virus from these animals demonstrate the persistent nature of FIV infection. Although these antibodies are highly effective in binding cell-free virus in vitro, they are unable to eliminate viral infection as shown by repeated virus isolation from these cats. This is similar to other lentivirus infections in which a cell-mediated immune response appears to be required for virus clearance (Kannagi et al., 1988; Chenciner et al., 1989; Riviere et al., 1989) . The majority of the sera from the experimental group of cats did not react or reacted weakly with FIV envelope proteins in Western blots, but still showed neutralizing activity; the loss of viral glycoproteins during virus purification is a possible explanation for this discrepancy. Like others (O'Connor et al., 1989) , we found that sera reacting solely with FIV core proteins in Western blots were able to precipitate viral envelope proteins when tested by radioimmunoprecipitation (data not shown). The MAbs described in this report provide a useful reagent for monitoring in vitro infection, for the detection of viral antigens in various pathological conditions and to study viral latency. They are essential for the detection of new FIV isolates in primary cultures of cat PBMCs and in cultures of bone marrow cells from experimentally FIV-infected cats.
